title: Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel.
authors.affiliation: Department of Medicinal Chemistry, Merck Research Laboratories, Merck & Co., Inc., West Point, PA 19486, USA. douglas_beshore@merck.com
authors.forename: Douglas C
authors.initials: DC
authors.lastname: Beshore
authors.forename: Nigel J
authors.initials: NJ
authors.lastname: Liverton
authors.forename: Charles J
authors.initials: CJ
authors.lastname: McIntyre
authors.forename: Christopher F
authors.initials: CF
authors.lastname: Claiborne
authors.forename: Brian
authors.initials: B
authors.lastname: Libby
authors.forename: J Christopher
authors.initials: JC
authors.lastname: Culberson
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Salata
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Regan
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Lynch
authors.forename: Laszlo
authors.initials: L
authors.lastname: Kiss
authors.forename: Robert H
authors.initials: RH
authors.lastname: Spencer
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Kane
authors.forename: Rebecca B
authors.initials: RB
authors.lastname: White
authors.forename: Suzie
authors.initials: S
authors.lastname: Yeh
authors.forename: George D
authors.initials: GD
authors.lastname: Hartman
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Dinsmore
mesh_terms: D000818:Animals; D004305:Dose-Response Relationship, Drug; D055808:Drug Discovery; D004353:Drug Evaluation, Preclinical; D004983:Ethanolamines / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D026902:Potassium Channel Blockers / Q000737:chemistry / Q000494:pharmacology*; D024642:Potassium Channels, Voltage-Gated / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship
chemical_list: D004983:Ethanolamines; C109966:KCNF1 protein, human; D026902:Potassium Channel Blockers; D024642:Potassium Channels, Voltage-Gated